Cutaneous T cell lymphoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
Conditions: Advanced Solid Tumor; Cutaneous T-cell Lymphoma (CTCL) Intervention: Drug: SIM1811-03 Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2022 Category: Research Source Type: clinical trials
